Also trades as: BCDAW (NASDAQ) · $vol 0M
BCDA NASDAQ
BioCardia, Inc.
1W: -11.4%
1M: -11.4%
3M: +19.1%
YTD: -27.4%
1Y: -33.7%
3Y: -94.7%
5Y: -99.3%
$0.92
+0.02 (+2.22%)
Weekly Expected Move ±10.7%
$1
$1
$1
$1
$1
Credit Risk of going bust: lower than 62% of companies Debt: 2.1% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.00 (down 99.7%), BioCardia, Inc. would be worth roughly what it owes.
Total debt $293K against a stock market value of $14.0M.
Distance to default 6.51 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $146K (short-term plus half of long-term), stock volatility 68.0%; Altman Z'' -123.97. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.00 (down 99.7%), BioCardia, Inc. would be worth roughly what it owes.
Total debt $293K against a stock market value of $14.0M.
Distance to default 6.51 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $146K (short-term plus half of long-term), stock volatility 68.0%; Altman Z'' -123.97. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
2 relationships2
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2021-03-29
Earliest Filing
2021-12-15
Latest Filing
partner: 1
investor: 1
Counterparties (Filed by BCDA)
2 relationshipsCompanies named in BCDA's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| The Irvine Company, LLC | — | partner | Lease agreement for manufacturing and office space | 2021-12-15 | View |
| Lincoln Park Capital Fund, LLC | — | investor | BioCardia, Inc. entered into a purchase agreement to sell up to $20,000,000 of common stock to Lincoln Park Capital Fund | 2021-03-29 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-10-19 | Other Events; Exhibits | View | |
| 2026-10-07 | Other Events; Exhibits | View | |
| 2026-10-01 | Other Events; Exhibits | View | |
| 2026-09-23 | Other Events; Exhibits | View | |
| 2026-09-21 | Other Events | View | |
| 2026-09-10 | Other Events; Exhibits | View | |
| 2026-08-24 | Regulation FD; Exhibits | View | |
| 2026-08-21 | Delisting Notice | View | |
| 2026-08-12 | Earnings Release; Exhibits | View | |
| 2026-06-18 | Regulation FD; Exhibits | View | |
| 2026-06-12 | Delisting Notice | View | |
| 2026-06-08 | Other Events; Exhibits | View | |
| 2026-06-05 | Regulation FD; Exhibits | View | |
| 2026-05-28 | Regulation FD; Exhibits | View | |
| 2026-05-21 | Regulation FD; Exhibits | View | |
| 2026-05-15 | Earnings Release; Exhibits | View | |
| 2026-05-08 | Regulation FD; Exhibits | View | |
| 2026-04-28 | Other Events; Exhibits | View | |
| 2026-04-20 | Regulation FD; Exhibits | View | |
| 2026-04-15 | Delisting Notice | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR